Sath Shukla

Affiliations

  • Ceo & President at Spero Therapeutics Inc. (SPRO), 2024-08-29
  • Evp, Chief Financial Officer at Ziopharm Oncology Inc (ZIOP), 2020-01-31
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SPRO $1.35 2,757 1,140,809 2024-08-27 Filing
SPRO $1.31 17,641 1,143,566 2024-08-05 Filing
SPRO $1.32 14,800 1,161,207 2024-08-02 Filing
SPRO $1.45 45,093 1,176,007 2024-02-05 Filing
SPRO $1.37 30,901 1,221,100 2024-02-02 Filing